发明名称 Perfusion solution
摘要 The invention provides a perfusion stock composition, for preserving a donor organ for transplantation, comprising: a source of 60 to 100 mM Na+; a source of 10 to 20 mM K+; a source of 5 to 10 mM Mg2+; a source of 0.25 to 0.75 mM Ca2+; 10 to 40 mM Tris(hydroxymethyl)aminomethane hydrochloride (Tris or THAM), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 3-(N-morpholino)propanesulfonic acid (MOPS), 2-(N-morpholino)ethanesulfonic acid (MES), N,/N-bis-(2-hydroxyethyl)-2-aminoethansulfonic acid (BES), or N/-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES); a source of 10 to 30 mM HC03−; 1 to 30 mM glucose; 1 to 20 U/L insulin; 1 to 10 mM fructose diphosphate or a salt thereof; 1 to 40 mM aspartate or glutamate; 1 to 10 mM adenosine, cAMP or cGMP; 1 to 10 mM reduced glutathione; and 30 to 100 mM lactobionate or mannitol; and optionally a diluent. The invention also provides a perfusion composition, a kit, a method, and a perfusion apparatus, each related to the perfusion stock composition.
申请公布号 US9060507(B2) 申请公布日期 2015.06.23
申请号 US201113818670 申请日期 2011.09.01
申请人 Perfusion Fluid Technologies Inc 发明人 Alford Marlin;Dowben Robert;Rosenfeldt Franklin
分类号 A01N1/02 主分类号 A01N1/02
代理机构 Law Offices of Ken Dallara 代理人 Law Offices of Ken Dallara ;Dallara Ken
主权项 1. A sterile aqueous solution for gravity microperfusion of donor hearts, the solution consisting of: (a) between 10 and 20 mM potassium chloride; (b) between 5 and 10 mM magnesium; (c) between 0.2 and 1.0 mM calcium; (d) between 10 and 40 mM Tris(hydroxymethyl)aminomethane hydrochloride (Tris or THAM), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HE PES), 3-(Nmorpholino)propanesulfonic acid (MOPS), 2-(N-morpholino)ethanesulfonic acid (MES), N,N-bis-(2-hydroxyethyl)-2-aminoethansulfonic acid (BES), or Ntris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES); (e) between 10 and 30 mM sodium bicarbonate, for enhancing the out-flow of CO2 from cells; (f) between 1 and 40 mM aspartate; (g) between 1 and 30 mM glucose; (h) between 1 and 20 mM adenosine, cAMP or cGMP; (i) between 30 and 100 mM lactobionate; (j) between 1 and 20 units/L insulin; (k) between 1 and 10 mM fructose diphosphate or a salt thereof; (l) between 1 and 10 mM reduced glutathione; (m) oxygen saturation using 100% 02; and (n) a sufficient concentration of sodium to maintain an ionic strength of sodium in said sterile aqueous solution is to be between 110 and 120 mM.
地址 Redlands CA US